Unlocking the Potential of Biomarkers: A Path to Improved Outcomes for Lung Cancer Patients
Lung cancer is one of the most common and deadly forms of cancer, with a five-year survival rate of only 21%. The key to improving outcomes for lung cancer patients lies in early detection and personalized treatment, and biomarkers have the potential to unlock these possibilities. Biomarkers are measurable substances in the body that can…